The data are in! Unimolecular multiagonists have demonstrated efficacy by concurrent activation of hormone receptors that affect energy homeostasis. During this dinner symposium, learn how emerging agents offer robust glucose control, with a low risk of hypoglycemia, as well as weight loss.